Medicine composition for treating cervical spondylosis

A composition and technology for cervical spondylosis, which are applied in the field of pharmaceutical compositions for the treatment of cervical spondylosis, can solve the problems of delayed effect, insignificant effect and high cost

Inactive Publication Date: 2016-01-27
王猛
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In the prior art, the methods for treating cervical spondylosis mainly include: drug therapy, physiotherapy, traction, massage, acupuncture, etc., but most of these methods have disadvantages such as long treatment course, insignificant effect, slow effect, and high cost. As a result, a large number of patients with cervical spondylosis suffer from long-term neck and shoulder pain, upper limb numbness, and muscle weakness due to lack of effective drug treatment, which seriously affects the quality of life

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Embodiment 1 prepares the pharmaceutical composition for the treatment of cervical spondylosis

[0012] The formula is: 35 grams of Citrus aurantium, 35 grams of Angelica, 25 grams of Wintergreen, 35 grams of Panax notoginseng, 25 grams of Caraway Seed, 30 grams of Pueraria lobata, 30 grams of Chuanduan, 35 grams of Angelica dahurica, 25 grams of Amaranth, rough leaf peat Moss 20 grams, Kudiding 20 grams, Gentiana 15 grams.

[0013] The preparation method is as follows: take each raw drug, pulverize it, pass through a 100-mesh sieve, mix, mix evenly, pack into capsules, and each capsule contains 0.5 grams of powder.

Embodiment 2

[0014] Embodiment 2 prepares the pharmaceutical composition for the treatment of cervical spondylosis

[0015] The formula is: 30 grams of Citrus aurantium, 33 grams of Angelica, 28 grams of Wintergreen, 30 grams of Panax notoginseng, 23 grams of Caraway Seed, 32 grams of Pueraria lobata, 25 grams of Chuanduan, 33 grams of Angelica dahurica, 28 grams of Amaranthus, charcoal moss 15 grams, Kudiding 18 grams, Gentiana 20 grams.

[0016] The preparation method is as follows: take each raw drug, pulverize it, pass through a 100-mesh sieve, mix, mix evenly, pack into capsules, and each capsule contains 0.5 grams of powder.

Embodiment 3

[0017] Embodiment 3 prepares the pharmaceutical composition for the treatment of cervical spondylosis

[0018] The formula is: 40 grams of Citrus aurantium, 38 grams of Angelica, 23 grams of Wintergreen, 40 grams of Panax notoginseng, 30 grams of Caraway Seed, 30 grams of Pueraria lobata, 28 grams of Chuanduan, 30 grams of Angelica dahurica, 30 grams of Amaranth, rough leaf peat Moss 22 grams, Diding 25 grams, Gentiana 10 grams.

[0019] The preparation method is as follows: take each raw drug, pulverize it, pass through a 100-mesh sieve, mix, mix evenly, pack into capsules, and each capsule contains 0.5 grams of powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition for treating cervical spondylosis. The medicine composition comprises, by weight, 30-40 parts of fructus aurantii immaturus, 30-40 parts of angelica sinensis, 20-30 parts of pyrola rotundifolia, 30-40 parts of panax notoginseng, 20-30 parts of carum carvi, 25-35 parts of radix puerariae, 25-35 parts of Himalayan teasel roots, 30-40 parts of angelica dahurica, 20-30 parts of aerva sanguinolenta, 15-25 parts of sphagnum squarrosum, 15-25 parts of herba corydalis bungeanae and 10-20 parts of gentiana macrophylla. A method for preparing the medicine composition includes grinding various raw materials; sieving the raw materials by the aid of 100-mesh sieves to obtain powder; uniformly mixing the powder to obtain medicine powder; filling each capsule with approximately 0.5 gram of the medicine powder. The capsules can be orally taken by three times on a daily basis when the cervical spondylosis is about to be treated, three capsules are taken with warm boiled water in each procedure, and a treatment course lasts for 10 days. The medicine composition can become effective obviously in 2-3 months generally, or the cervical spondylosis can be cured in 2-3 months generally, and the cervical spondylosis can be cured for severe patients in 6 months. The medicine composition has the advantages that the medicine composition can become effective fast, obvious treatment effects can be realized, and the like.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating cervical spondylosis. Background technique [0002] For the staff engaged in file management, they need to sit in front of the computer desk or desk for a long time to sort out the file materials, and lack of exercise at ordinary times, it is easy to suffer from cervical spondylosis. Cervical spondylosis, also known as cervical syndrome, is a disease based on degenerative pathological changes, mainly due to long-term cervical strain, bone hyperplasia, or intervertebral disc prolapse, and ligament thickening, resulting in cervical spinal cord, nerve root or vertebral artery compression , a clinical syndrome of a series of functional impairments, the main symptoms are head, neck, shoulder, back, arm pain, neck stiffness, limited mobility, if the disease is not cured for a long time, it will cause psychological damage, insomnia, irritability, anger, anxiety , depression and other symptoms...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/898A61K36/752A61P19/08A61P29/00
Inventor 王猛颜景春
Owner 王猛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products